Gainers & Losers
Mon Nov 25 2024 10:23:34- Larsen & Toubro share price
- ₹3,753.254.13%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
- Wipro share price
- ₹582.751.99%
- ICICI Bank share price
- ₹1,301.501.82%
Active Stocks
Mon Nov 25 2024 10:27:51- Adani Power share price
- ₹446.85-3.02%
- Power Grid Corporation Of ...
- ₹342.851.74%
- Tata Steel share price
- ₹143.600.56%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
Mankind Pharma Profit & Loss Annual
Trade2,628.00 +76.45 (3.00%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 10,334.77 | 8,749.43 | 7,781.56 | 6,214.43 |
| Total Revenue | 10,334.77 | 8,749.43 | 7,781.56 | 6,214.43 |
| Costof Revenue Total | 3,397.85 | 3,071.29 | 2,573.14 | 1,907.51 |
| Gross Profit | 6,936.92 | 5,678.15 | 5,208.42 | 4,306.93 |
| Selling/ General/ Admin Expenses Total | 3,306.91 | 3,763.95 | 3,209.56 | 2,583.60 |
| Depreciation/ Amortization | 398.20 | 325.86 | 166.56 | 118.92 |
| Interest Exp( Inc) Net- Operating Total | 0.55 | 0.55 | 0.53 | 0.55 |
| Unusual Expense( Income) | 8.26 | 13.56 | -19.75 | 21.60 |
| Other Operating Expenses Total | 1,084.43 | - | - | 50.58 |
| Total Operating Expense | 8,195.70 | 7,174.72 | 5,929.56 | 4,682.26 |
| Operating Income | 2,139.08 | 1,574.72 | 1,851.99 | 1,532.18 |
| Interest Inc( Exp) Net- Non- Op Total | 1,369.13 | 365.31 | 1,074.43 | 979.09 |
| Gain( Loss)on Saleof Assets | 94.46 | 103.14 | 31.15 | 10.06 |
| Other Net | 113.92 | 49.68 | 12.05 | 60.52 |
| Net Income Before Taxes | 2,399.36 | 1,671.24 | 1,974.60 | 1,691.61 |
| Provisionfor Income Taxes | 457.59 | 361.56 | 521.64 | 398.58 |
| Net Income After Taxes | 1,941.77 | 1,309.68 | 1,452.96 | 1,293.03 |
| Minority Interest | -28.88 | -27.82 | -19.48 | -27.61 |
| Net Income Before Extra Items | 1,912.90 | 1,281.86 | 1,433.48 | 1,265.43 |
| Net Income | 1,912.90 | 1,281.86 | 1,433.48 | 1,265.43 |
| Income Availableto Com Excl Extra Ord | 1,912.90 | 1,281.86 | 1,433.48 | 1,265.43 |
| Income Availableto Com Incl Extra Ord | 1,912.90 | 1,281.86 | 1,433.48 | 1,265.43 |
| Diluted Net Income | 1,912.90 | 1,281.86 | 1,433.48 | 1,265.43 |
| Diluted Weighted Average Shares | 40.12 | 40.06 | 40.06 | 40.06 |
| Diluted EPS Excluding Extra Ord Items | 47.68 | 32.00 | 35.78 | 31.59 |
| Diluted Normalized EPS | 47.66 | 32.06 | 35.36 | 31.98 |
*All figures in crores except per share values
Mankind Pharma Quick Links
Mankind Pharma Dividend Mankind Pharma Bonus Mankind Pharma News Mankind Pharma AGM Mankind Pharma Rights Mankind Pharma Splits Mankind Pharma Board Meetings Mankind Pharma Key Metrics Mankind Pharma Shareholdings Mankind Pharma Balance Sheet Mankind Pharma Cashflow Mankind Pharma Q1 Results Mankind Pharma Q2 Results Mankind Pharma Q3 Results Mankind Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,753.25+148.70(4.13%)
844.75+28.70(3.52%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)